Tectonic Therapeutic to Participate in December Investor Conferences GlobeNewswire December 01, 2025 WATERTOWN, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that company […]
Rezolve Ai Defines the Future of Commerce with Acquisition of Crownpeak GlobeNewswire December 01, 2025 Deal to Add approximately $70M Revenue and is immediately EBITDA-accretive, Expanding “Brain Commerce” Footprint Across US, UK & EMEA Advances roll-up strategy for upselling traditional search platforms and strengthens Rezolve's enterprise AI footprint across global markets A strategic 'return' for
Targeted Drugs for Allergic Diseases Market Set to Hit USD 30.22 Billion by 2034, Driven by Rising Allergic Disorders The global targeted drugs for allergic diseases market size was valued at USD 13.96 billion in 2024 and is predicted to hit around USD 30.22 billion by 2034, rising at a 8.06% CAGR, a study published
American Rebel Holdings, Inc. (NASDAQ: AREB) Adds C & C Distributors to Advance American Rebel Light Beer's Distribution-First Growth Strategy in Arkansas GlobeNewswire December 01, 2025 Family-owned Anheuser-Busch wholesaler extends American Rebel Light's patriotic footprint across northeast Arkansas with deep local relationships, high-volume channel access, and a 30+ year track record of brand building NASHVILLE,
Tokyo Lifestyle Announces Strategic Investment Partnership to Accelerate Expansion in Hong Kong and Australia GlobeNewswire December 01, 2025 Tokyo, Japan, Dec. 01, 2025 (GLOBE NEWSWIRE) — Tokyo Lifestyle Co., Ltd. (“Tokyo Lifestyle” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, collectible cards,
PodcastOne And Dr. Phil's Envoy Media Co. Join Forces To Launch New Television, DTC and Podcast Based Original and Owned Content Network, Led By All New Daily Dr. Phil Podcast GlobeNewswire December 01, 2025 Premieres to Over 125 Million Pay Cable Subscribers and Free Streaming Viewers Via Envoy TV and Envoy FAST Channels, Dr. Phil
Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025 GlobeNewswire December 01, 2025 ROCKVILLE, Md. and SUZHOU, China, Dec. 01, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company“), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel,
Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study GlobeNewswire December 01, 2025 Salarius subsidiary Decoy Therapeutics' influenza fusion inhibitors, designed using its proprietary IMP3ACT(TM) platform, show excellent in silico free energy binding to the viral target entry protein, supporting potential for anti-flu activity IMP3ACT's demonstrated capability to create a single
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions GlobeNewswire December 01, 2025 BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) — Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (NASDAQ: NEUP), a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders, today issued the following
Fancamp Announces Spin-Out of Mineral Exploration Assets and Creation of Goldera Exploration GlobeNewswire December 01, 2025 VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Corporation“) (TSX Venture Exchange: FNC) is pleased to announce that its Board of Directors (the “Fancamp Board“) has unanimously approved a strategic reorganization of